Mitchell M A, Markovitz D M, Killen P D, Braun D K
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0378.
Clin Infect Dis. 1994 May;18(5):704-18. doi: 10.1093/clinids/18.5.704.
Malacoplakia is a rare inflammatory disorder seen most often in the urinary tract, where it is highly associated with coliform infection. Although first recognized by pathologists in 1902, it has received little attention from the infectious disease community. While there remains much uncertainty regarding the specific cause of malacoplakia, it appears to be associated with a defect in intracellular killing of ingested microorganisms by macrophages. We report a case of bilateral renal parenchymal malacoplakia that presented as fever of unknown origin, and we review 33 previously identified cases. Renal malacoplakia has traditionally been associated with high morbidity and mortality. More recently, treatment with antimicrobial agents such as trimethoprim or ciprofloxacin has yielded a better outcome than had been documented with other therapy. Malacoplakia should be considered in the evaluation of fever of unknown origin or of relapsing or refractory urinary tract infection. Therapy with antimicrobial agents capable of intracellular penetration is recommended.
软斑病是一种罕见的炎症性疾病,最常见于泌尿系统,与大肠埃希菌感染高度相关。尽管病理学家于1902年首次发现该病,但一直未受到传染病学界的太多关注。虽然软斑病的具体病因仍存在诸多不确定性,但它似乎与巨噬细胞对摄入微生物的细胞内杀伤缺陷有关。我们报告了一例表现为不明原因发热的双侧肾实质软斑病病例,并回顾了33例先前确诊的病例。传统上,肾软斑病与高发病率和死亡率相关。最近,使用甲氧苄啶或环丙沙星等抗菌药物治疗的效果比其他治疗方法更好。在评估不明原因发热或复发性或难治性尿路感染时应考虑软斑病。建议使用能够穿透细胞内的抗菌药物进行治疗。